US Patent

US9101592 — Stabilized granules containing glyceryl trinitrate

Formulation · Assigned to G Pohl Boskamp GmbH and Co KG · Expires 2032-03-11 · 6y remaining

Vulnerability score 48/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects a stabilized pharmaceutical preparation containing glyceryl trinitrate for oromucosal or oral administration with specific composition requirements.

USPTO Abstract

Solid pharmaceutical preparation with the active substance glyceryl trinitrate for oromucosal or oral administration characterized in that it contains between 0.05 and 2 weight % glyceryl trinitrate, at least one carrier material, and at least one substance that reduces the volatility of the GTN, whereby this substance is a non-volatile ester stabilizer.

Drugs covered by this patent

Patent Metadata

Patent number
US9101592
Jurisdiction
US
Classification
Formulation
Expires
2032-03-11
Drug substance claim
No
Drug product claim
Yes
Assignee
G Pohl Boskamp GmbH and Co KG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.